Omentectomy added to Roux-en-Y gastric bypass surgery: A randomized, controlled trial

Surgery for Obesity and Related Diseases

Volumn 9, Issue 2, 2013, Pages 269-275

  Dillard, Troy H ^a   Purnell, Jonathan Q ^a   Smith, Mark D ^b   Raum, William ^b   Hong, Dennis ^b   Laut, Jamie ^c   Patterson, Emma J ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LEGACY GOOD SAMARITAN HOSPITAL   (United States)

^c ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Adiponectin; Bariatric surgery; Gastric bypass surgery; High molecular weight adiponectin; Intra abdominal adipose; Obesity; Omentectomy; Omentum; Roux en Y; Visceral adipose

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HOMOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LIPID METABOLISM; MALE; OMENTECTOMY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ROUX Y ANASTOMOSIS; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ABDOMINAL FAT; ADIPOKINES; ADULT; AGED; BLOOD GLUCOSE; FASTING; FEMALE; GASTRIC BYPASS; HUMANS; LAPAROSCOPY; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY; OMENTUM; POSTOPERATIVE CARE; SINGLE-BLIND METHOD; WEIGHT LOSS;

EID: 84875481838     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2011.09.027     Document Type: Article

References (30)

1. A. Misra, L. Khurana Obesity and the metabolic syndrome in developing countries J Clin Endocrinol Metab 93 2008 S9 S30
2. B. Balkau, J.E. Deanfield, J.P. Després International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries Circulation 116 2007 1942 1951
3. S. Yusuf, S. Hawken, S. Ôunpuu Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study Lancet 366 2005 1640 1649
4. S.R. Colberg, J.A. Simoneau, F.L. Thaete, D.E. Kelley Skeletal muscle utilization of free fatty acids in women with visceral obesity J Clin Invest 95 1995 1846 1853
5. D.G. Carey, A.B. Jenkins, L.V. Campbell, J. Freund, D.J. Chisholm Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM Diabetes 45 1996 633 638
6. A. Cartier, I. Lemieux, N. Alméras, A. Tremblay, J. Bergeron, J.P. Després Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men J Clin Endocrinol Metab 93 2008 1931 1938
7. H. Xu, G.T. Barnes, Q. Yang Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830
8. N. Maeda, I. Shimomura, K. Kishida Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 Nat Med 8 2002 731 737
9. M.B. Snijder, R.J. Heine, J.C. Seidell Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn study Diabetes Care 29 2006 2498 2503
10. J. Spranger, A. Kroake, M. Möhlig Adiponectin and protection against type 2 diabetes mellitus Lancet 361 2003 226 228
11. M. Côté, P. Mauriège, J. Bergeron Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men J Clin Endocrinol Metab 90 2005 1434 1439
12. S.H. Jain, J.M. Massaro, U. Hoffmann Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study Diabetes Care 32 2009 903 908
13. R. Basu, U.B. Pajvani, R.A. Rizza, P.E. Scherer Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects Diabetes 56 2007 2174 2177
14. H. Kobayashi, N. Ouchi, S. Kihara Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin Circ Res 94 2004 e27 e31
15. S. Klein, L. Fontana, V.L. Young Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease N Engl J Med 350 2004 2549 2557
16. N. Barzilai, L. She, B.Q. Liu Surgical removal of visceral fat reverses hepatic insulin resistance Diabetes 48 1999 94 98
17. C. Pitombo, E.P. Araújo, C.T. De Souza, J.C. Pareja, B. Geloneze, L.A. Velloso Amelioration of diet-induced diabetes mellitus by removal of visceral fat J Endocrinol 191 2006 699 706
18. Y.W. Kim, J.Y. Kim, S.K. Lee Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue in monosodium glutamate (MSG)-obese rats J Korean Med Sci 14 1999 539 545
19. M. Lottati, C.M. Kolka, D. Stefanovski, E.L. Kirkman, R.N. Bergman Greater omentectomy improves insulin sensitivity in nonobese dogs Obes Silver Spring 17 2009 674 680
20. A. Thörne, F. Lönngvist, J. Apelman, G. Hellers, P. Arner A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding Int J Obes Relat Metab Disord 26 2002 193 199
21. A. Csendes, F. Maluenda, A.M. Burgos A prospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy Obes Surg 19 2009 490 494
22. M.F. Herrera, J.P. Pantoja, D. Velázquez-Fernández Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial Diabetes Care 33 2010 1413 1418
23. M.M. Lima, J.C. Pareja, S.M. Alegre Acute effect of Roux-en-Y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic- hyperinsulinemic clamp J Clin Endocrinol Metab 95 2010 3871 3875
24. E. Fabbrini, R.A. Tamboli, F. Magkos Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults Gastroenterology 139 2010 448 455
25. J.P. Hosker, D.R. Matthews, A.S. Rudenski Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man Diabetologia 28 1985 401 411
26. J.Q. Purnell, S.E. Kahn, R.S. Schwartz, J.D. Brunzell Relationship of insulin sensitivity and ApoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia Arterioscler Thromb Vasc Biol 21 2001 567 572
27. C. Weyer, C. Bogardus, D.M. Mott, R.E. Pratley The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus J Clin Invest 104 1999 787 794
28. A. Festa, K. Williams, R. D'Agostino Jr, L.E. Wagenknecht, S.M. Haffner The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study Diabetes 55 2006 1114 1120
29. H.C. Lee, M.K. Kim, H.S. Kwon, E. Kim, K.H. Song Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients Obes Surg 20 2010 1530 1535
30. H. Buchwald, D.M. Oien Metabolic/bariatric surgery worldwide 2008 Obes Surg 19 2009 1605 1611